Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

908
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
908
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

924
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
924
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

941
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
941
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

203
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
203
Structure of Lipids03:38

Structure of Lipids

87.5K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
87.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Precision Medicine for Electrocardiogram Interpretation: Clinical Relevance, Challenges, and Advances.

Reviews in cardiovascular medicine·2026
Same author

Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF.

Journal of cardiovascular electrophysiology·2025
Same author

Palpitations After Leadless Pacemaker Implantation.

Circulation·2025
Same author

Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Impact of Diagnosis to Ablation Time on Recurrence of Atrial Fibrillation and Clinical Outcomes After Catheter Ablation: A Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Mitigation of pacing-induced cardiomyopathy with superficial right ventricular mid-septal pacing: A long-term retrospective comparison with apical pacing.

Journal of cardiovascular electrophysiology·2024
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 17, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.7K

Ácidos grasos omega-3 y arritmias

Mason D Marcus1, Mark S Link1

  • 1Department of Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX.

Circulation
|August 5, 2024
PubMed
Resumen
Este resumen es generado por máquina.

Los ácidos grasos omega-3 (PUFA n-3) muestran resultados mixtos para el ritmo cardíaco. Si bien algunos estudios sugieren beneficios, las dosis altas pueden aumentar el riesgo de fibrilación auricular (FA), con mecanismos aún no claros.

Palabras clave:
Fibrilación auricularÁcido docosahexaenoicoÁcido eicosapentaenoicoÁcidos grasos omega-3

Más Videos Relacionados

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

3.6K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.7K

Videos de Experimentos Relacionados

Last Updated: Jun 17, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.7K
Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

3.6K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.7K

Área de la Ciencia:

  • Cardiología
  • Farmacología
  • La bioquímica

Sus antecedentes:

  • Los ácidos grasos poliinsaturados omega-3 (PUFA n-3) han sido investigados tanto para efectos pro como antiarrítmicos.
  • Los primeros estudios sugirieron que los PUFA n-3 podrían prevenir la muerte súbita cardíaca y la fibrilación auricular (FA).
  • Sin embargo, recientes grandes ensayos aleatorios han dado resultados contradictorios con respecto a sus beneficios antiarrítmicos.

Objetivo del estudio:

  • Evaluar los efectos complejos y a menudo contradictorios de los AGPI n-3 sobre las arritmias cardíacas, en particular la FA.
  • Evaluar la evidencia clínica actual con respecto a la eficacia y seguridad de la suplementación con AGPI n-3 para la prevención cardiovascular y el tratamiento de la FA.
  • Investigar los posibles efectos proarrítmicos de las formulaciones y dosis específicas de AGPI n-3.

Principales métodos:

  • Revisión de los estudios preclínicos y los ensayos clínicos en humanos, incluidos los ensayos controlados aleatorios (ECA).
  • Análisis de los datos de ECA contemporáneos de gran tamaño que investigan dosis moderadas y altas de ácidos PUFA n-3 (incluido el ácido eicosapentaenoico (EPA) y el ácido docosahexaenoico (DHA)) para la prevención cardiovascular.
  • Examen de los hallazgos relacionados con la FA incidente en los participantes que recibieron N-3 PUFA en comparación con los grupos de control.

Principales resultados:

  • La evidencia acumulada no apoya la suplementación con AGPI n-3 para la prevención de la FA postoperatoria o secundaria.
  • Varios ECA de gran tamaño demostraron un aumento pequeño y significativo, dependiente de la dosis, en la incidencia de FA con dosis altas de PUFA n-3 (icosapentetil o EPA+DHA) en comparación con el placebo.
  • Estos hallazgos proarrítmicos se observaron tanto en monoterapia como en formulaciones mixtas, pero los mecanismos subyacentes siguen siendo desconocidos.

Conclusiones:

  • La utilidad clínica de los AGPI n-3 para prevenir las arritmias cardíacas, especialmente la FA, es incierta y potencialmente controvertida.
  • La suplementación con altas dosis de AGPI n-3, incluidas formulaciones específicas como el icosapentetil, puede aumentar el riesgo de desarrollar FA.
  • Se necesita más investigación para dilucidar los complejos mecanismos pro y antiarrítmicos de EPA, DHA y sus metabolitos, y para identificar subgrupos de pacientes con mayor riesgo.